Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights in ubiquitin-dependent Wnt receptor regulation in tumorigenesis. | In Vitro Cell Dev Biol Anim | 2024 | 38383910 | PubTator, text mining | PubMed |
| R-Spondin 2 governs Xenopus left-right body axis formation by establishing an FGF signaling gradient. | Nat Commun | 2024 | 38307837 | PubTator, text mining | PubMed |
| The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. | Genes Dis | 2024 | 38292186 | PubTator, text mining | PubMed |
| Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma. | BMC Med | 2024 | 38281914 | PubTator, text mining | PubMed |
| The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers. | Cancers (Basel) | 2024 | 38275886 | PubTator, text mining | PubMed |
| Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design. | Biomedicines | 2024 | 38275417 | PubTator, text mining | PubMed |
| Transposable elements mediate genetic effects altering the expression of nearby genes in colorectal cancer. | Nat Commun | 2024 | 38272908 | PubTator, text mining | PubMed |
| Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer. | bioRxiv | 2024 | 38260423 | PubTator, text mining | PubMed |
| Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications. | Int J Mol Sci | 2024 | 38256131 | PubTator, text mining | PubMed |
| Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients. | BMC Cancer | 2024 | 38238650 | PubTator, text mining | PubMed |
| RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells. | Adv Sci (Weinh) | 2024 | 38225722 | PubTator, text mining | PubMed |
| Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges. | Technol Cancer Res Treat | 2024 | 38225190 | PubTator, text mining | PubMed |
| CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value. | J Immunother Cancer | 2024 | 38212126 | PubTator, text mining | PubMed |
| Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer. | Ther Adv Med Oncol | 2024 | 38205077 | PubTator, text mining | PubMed |
| Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review. | Gut | 2024 | 38195219 | PubTator, text mining | PubMed |
| R-spondin-1 induces Axin degradation via the LRP6-CK1ε axis. | Cell Commun Signal | 2024 | 38183076 | PubTator, text mining | PubMed |
| Role of Influenza A virus protein NS1 in regulating host nuclear body ND10 complex formation and its involvement in establishment of viral pathogenesis. | PLoS One | 2024 | 38166085 | PubTator, text mining | PubMed |
| Integrative analysis of co-expression pattern of solute carrier transporters reveals molecular subtypes associated with tumor microenvironment hallmarks and clinical outcomes in colon cancer. | Heliyon | 2024 | 38163210 | PubTator, text mining | PubMed |
| Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family. | Fam Cancer | 2024 | 38063999 | PubTator, text mining | PubMed |
| DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations. | J Clin Oncol | 2024 | 37992266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=9